Thursday, September 6, 2018 Presentations
- Biomarker Based Non-endoscopic Detection of Barrett’s Esophagus (BE) and Esophageal Adenocarcinoma (EAC)
- Prostate Cancer Detection Collaborative Group
- Advances in Detection of DNA Methylation: Application to Lung Cancer Screening
- The Road to Early Detection of Pancreatic Cancer
- Challenges and Opportunities for the EDRN
- GI Collaborative Overview: Colon and Esophageal Cancer
- Thoughts on the Nature of Neoplasia
- Identification of Candidate Biomarkers for Early Detection of Aggressive Prostate Cancer using Targeted Proteomics
- Towards Early Cancer Detection through EV Analysis
- The Future of Biomarkers – Post Translation Modification
- Salient Report from Breast/GYN EDRN Team
- Leveraging the Transcriptome for The Early Detection of Prostate Cancer
- Breast Cancer Detection Consortium
- Moffitt's Imaging Biomarker Validation Center (MIBVAC): Applying Radiomics in Early Detection of Lung Cancer
- PapSEEK, PapDREAMing & Proteomics for Early Detection
- Salient Report from the Lung Collaborative Group
- Highlights of the EDRN Pancreas Collaborative Group
- Blood-based Screening and Monitoring of Colorectal Cancer